KIMBERLY DORE: Open Payments
NPI 1568220754 · STATEN ISLAND, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$659 in 19 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $287 · 2025 $659
Food & beverage: $659
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 6 | $145 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $125 |
| Lundbeck LLC | 1 | $125 |
| PFIZER INC. | 4 | $88 |
| ARGENX US, INC. | 3 | $87 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| Janssen Biotech, Inc. | 1 | $24 |
| ABBVIE INC. | 1 | $23 |
Products named: AMVUTTRA, HYQVIA, VYEPTI, NURTEC ODT, VYVGART, WAINUA, BOTOX.
Industry payments across NY — which companies pay providers there.
